AtaiBeckley Inc. (ATAI)
NASDAQ: ATAI · Real-Time Price · USD
3.850
-0.085 (-2.16%)
Feb 10, 2026, 4:00 PM EST - Market closed
AtaiBeckley Market Cap
AtaiBeckley has a market cap or net worth of $1.4 billion as of February 11, 2026. Its market cap has increased by 474.68% in one year.
Market Cap
1.40B
Enterprise Value
1.29B
1-Year Change
474.68%
Ranking
Category
Stock Price
$3.85
Market Cap Chart
Since the IPO on June 18, 2021, AtaiBeckley's market cap has decreased from $2.29B to $1.40B, a decrease of -38.90%. That is a compound annual growth rate of -10.05%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 10, 2026 | 1.40B | -5.87% |
| Dec 31, 2025 | 1.49B | 565.59% |
| Dec 31, 2024 | 223.18M | -4.66% |
| Dec 29, 2023 | 234.07M | -46.95% |
| Dec 30, 2022 | 441.23M | -63.92% |
| Dec 31, 2021 | 1.22B | -46.56% |
| Jun 18, 2021 | 2.29B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Upstream Bio | 1.50B |
| Kodiak Sciences | 1.45B |
| Trevi Therapeutics | 1.44B |
| Novavax | 1.42B |
| DBV Technologies | 1.42B |
| AnaptysBio | 1.39B |
| Intellia Therapeutics | 1.38B |
| Rapport Therapeutics | 1.35B |